Association of a myeloperoxidase promoter polymorphism with multiple sclerosis

被引:28
作者
Kantarci, OH
Atkinson, EJ
Hebrink, DD
McMurray, CT
Weinshenker, BG
机构
[1] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Pharmacol, Rochester, MN 55905 USA
[4] Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[5] Mayo Clin & Mayo Fdn, Mol Neurosci Program, Rochester, MN 55905 USA
关键词
genetics; multiple sclerosis; myeloperoxidase; prognosis; susceptibility;
D O I
10.1016/S0165-5728(00)00198-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myeloperoxidase (MPO) generates hypochlorous acid and other reactive oxygen intermediates leading to tissue damage. MPO is expressed in macrophages-microglia in multiple sclerosis (MS) lesions. A G-->A substitution that abolishes an SP1 transcription factor consensus sequence in the promoter reduces gene expression. We studied the association of the genetic variant with MS. We did not find an association with gender, age at onset, susceptibility to, or the course and severity of MS in a population-based sample of 112 patients from Olmsted County. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 18 条
[1]  
AUSTIN GE, 1993, LEUKEMIA, V7, P1445
[2]   A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosis [J].
Chataway, J ;
Sawcer, S ;
Feakes, R ;
Coraddu, F ;
Broadley, S ;
Jones, HB ;
Clayton, D ;
Gray, J ;
Goodfellow, PN ;
Compston, A .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 98 (02) :208-213
[3]   3-chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima [J].
Hazen, SL ;
Heinecke, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (09) :2075-2081
[5]   Survival and predictors of disability in Turkish MS patients [J].
Kantarci, O ;
Siva, A ;
Eraksoy, M ;
Karabudak, R ;
Sütlas, N ;
Agaoglu, J ;
Turan, F ;
Özmenoglu, M ;
Togrul, E ;
Demirkiran, M .
NEUROLOGY, 1998, 51 (03) :765-772
[6]   Genomewide scan of multiple sclerosis in Finnish multiplex families [J].
Kuokkanen, S ;
Gschwend, M ;
Rioux, JD ;
Daly, MJ ;
Terwilliger, JD ;
Tienari, PJ ;
Wikström, J ;
Palo, J ;
Stein, LD ;
Hudson, TJ ;
Lander, ES ;
Peltonen, L .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (06) :1379-1387
[7]  
London SJ, 1997, CANCER RES, V57, P5001
[8]   Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis [J].
Nagra, RM ;
Becher, B ;
Tourtellotte, WW ;
Antel, JP ;
Gold, D ;
Paladino, T ;
Smith, RA ;
Nelson, JR ;
Reynolds, WF .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 78 (1-2) :97-107
[9]   Hypochlorous acid N-chloramines are naturally produced DNA repair inhibitors [J].
Pero, RW ;
Sheng, YZ ;
Olsson, A ;
Bryngelsson, C ;
LundPero, M .
CARCINOGENESIS, 1996, 17 (01) :13-18
[10]   An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element [J].
Piedrafita, FJ ;
Molander, RB ;
Vansant, G ;
Orlova, EA ;
Pfahl, M ;
Reynolds, WF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) :14412-14420